Erratum to "Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria" [General Hospital Psychiatry 31 (2009) 167-174] (DOI:10.1016/j.genhosppsych.2008.12.005);Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria

General Hospital Psychiatry

Volumn 31, Issue 2, 2009, Pages 167-174

  Adewuya, Abiodun O ^a   Owoeye, Olugbenga A ^b   Erinfolami, Adebayo R ^c   Coker, Ayodele O ^a   Ogun, Oluyemi C ^b   Okewole, Adeniran O ^b   Dada, Mobolaji U ^b   Eze, Christian N ^b   Bello Mojeed, Mashudat A ^b   Akindipe, Taiwo O ^c   Olagunju, Andrew T ^c   Etim, Etop ^c  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b Federal Neuropsychiatric Hospital   (Nigeria)

^c UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE DURATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FUNCTIONAL STATUS; HEALTH CARE COST; HOSPITAL ORGANIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL DISEASE; MENTAL HEALTH; MENTAL PATIENT; MORISKY MEDICATION ADHERENCE QUESTIONNAIRE; NIGERIA; OUTPATIENT CARE; PATIENT ATTITUDE; PERCEPTION; PREVALENCE; PROGNOSIS; QUESTIONNAIRE; RELIGION; SEX; SIDE EFFECT; SOCIAL SUPPORT; STIGMA; TREATMENT FAILURE;

EID: 61649100029     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2009.11.008     Document Type: Erratum

References (33)

1. Llorca P.M., Miadi-Fargier H., Lançon C., et al. Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation. Encephale 31 (2005) 235-246
2. Coldham E.L., Addington J., and Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 106 (2002) 286-290
3. Ascher-Svanum H., Faries D.E., Zhu B., Ernst F.R., Swartz M.S., and Swanson J.W. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 67 (2006) 453-460
4. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., and Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 16 2 (2008) CD000011
5. Diaz E., Neuse E., Sullivan M.C., Pearsall H.R., and Woods S.W. Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry 65 (2004) 354-360
6. El-Mallakh R.S. Medication adherence and the use of long-acting antipsychotics in bipolar disorder. J Psychiatr Pract 13 (2007) 79-85
7. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., and Jetse D.V. Prevalence of and risk for medication adherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63 (2002) 892-909
8. Kikkert M.J., Barbui C., Koeter M.W., et al. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research. J Nerv Ment Dis 196 (2008) 274-281
9. Olfson M., Marcus S.C., Wilk J., and West J.C. Awareness of illness and non-adherence to antipsychotic medications among persons with schizophrenia. Psychiatr Serv 57 (2006) 205-211
10. Adewuya A.O., Ola B.A., Mosaku S.K., Fatoye F.O., and Eegunranti A.B. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatr Scand 113 (2006) 207-211
11. Sheehan D.V., Lecrubier Y., Harnett-Sheehan K., et al. The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 59 Suppl 20 (1998) 22-33
12. Overall J.E., and Gorham D.K. The Brief Psychiatry Rating Scale. Psychol Rep 10 (1962) 799-812
13. Molloy D.W., Alemayehu E., and Roberts R. Reliability of a Standard Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry 148 (1991) 102-105
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington DC
15. Hogan T.P., Awad A.G., and Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13 (1983) 177-183
16. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self reported measure of medication adherence. Med Care 24 (1986) 67-74
17. Ritsher J.B., Otilingam P.G., and Grajales M. Internalised stigma of mental illness: psychometric properties of a new measure. Psychol Res 121 (2003) 31-49
18. Kamali M., Kelly B.D., Clarke M., et al. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry 21 (2006) 29-33
19. Valenstein M., Ganoczy D., McCarthy J.F., Myra Kim H., Lee T.A., and Blow F.C. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry 67 (2006) 1542-1550
20. Freudenreich O., Cather C., Evins A.E., Henderson D.C., and Goff D.C. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 65 (2004) 1372-1376
21. Hofer A., Kemmler G., Eder U., Honeder M., Hummer M., and Fleischacker W.W. Attitudes towards antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry 63 (2002) 49-53
22. Fenton W.S., Byler C., and Heinsesen R. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 23 (1997) 637-651
23. Gracia J.I., Chang C.L., Young J.S., Lopez S.R., and Jenkins J.H. Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 41 (2006) 624-631
24. Angermeyer M., and Matschinger H. The stigma of mental illness: effects of labeling on public attitudes towards people with mental disorder. Acta Psychiatr Scand 108 (2003) 304-309
25. Gaebel W., Zäske H., and Baumann A. The relationship between mental illness severity and stigma. Acta Psychiatr Scand 113 (2006) 41-45
26. Sirey J.A., Bruce M.L., Alexopoulos G.S., et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 158 (2001) 479-481
27. Elkin I., Yamaguchi J.L., and Arnkoff D.B. "Patients-treatment fit" and early engagement in psychotherapy. Psychother Res 9 (1999) 437-451
28. Adewuya A.O., and Makanjuola R.O.A. Lay beliefs regarding causes of mental illness in Nigeria. Soc Psychiatry Psychiatr Epidemiol 43 (2008) 336-341
29. Perkins D.O., Johnson J.L., Hamer R.M., et al. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 83 (2006) 53-63
30. Droulout T., Liraud F., and Verdoux H. Relationships between insight and medication adherence in subjects with psychosis. Encephale 29 (2003) 430-437
31. Day J.C., Bentall R.P., Roberts C., et al. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62 (2005) 717-724
32. Valenstein M., Copeland L.A., Owen R., Blow F.C., and Visnic S. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J Clin Psychiatry 62 (2001) 545-551
33. Valenstein M., Blow F.C., Copeland L.A., et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 30 (2004) 255-264